Re: 'is lipid profile determination necessary in women wishing to use oral contraceptives?' by Machado RB et al.

摘要

To the Editor: I read with great attention the manuscript "Is lipid profile determination necessary in women wishing to use oral contraceptives?" from Machado RB et al. accepted for publication in Contraception [1]. The authors conducted a cross-sectional study in which women who requested the use of different contraceptive methods were tested for lipid profile. The main findings showed low high-density lipoprotein (16.3%), hypercholester-olemia (13.8%), hypertriglyceridemia (11.8%) and elevated low-density lipoprotein (4.1%). In addition, 13.6% of the women presented a body mass index (BMI) > 27.3 kg/m2 and 12.6% were smokers. The prevalence of dyslipidemias was 33.9%. Based on these result the authors concluded: "...the high prevalence of dyslipidemia could justify measurement of the lipid profile evaluation before prescribing a COC, regardless of the presence of clinically identifiable risk factors."